This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Colorado Passes Bill Banning Most Physician Non-Compete Agreements

Ever since a reference to a "legislative ban on physician non-compete agreements" was made in the Colorado attorney general's Stipulated Consent Agreement and Judgment with U.S. Anesthesia Partners of Colorado, Inc., filed Feb. 26, 2024, health law practitioners in Colorado have waited to see if the Colorado General Assembly would enact such a ban...

United States Healthcare

GT

Greenberg Traurig, LLP

Health Care Marketing: The Seventh Circuit Addresses "Referrals" Under The Anti-Kickback Statute

Health care organizations working with marketers, independent sales representatives, advertising, and other consulting support to promote sales of products or services received welcomed news...

United States Healthcare

FL

Foley & Lardner

What To Do When You Receive A DEA Order To Show Cause

We published a version of this post several years back (see here), but recent updates to the law and trends in DEA enforcement merit a refresher.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Off-Cycle Medicare Revalidations For SNFs – Deadline Extended To August 1, 2025

On April 17, 2025, the Centers for Medicare and Medicaid Services ("CMS") announced via a Medicare Learning Network ("MLN") update that the deadline for submission...

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

How West Virginia's HB 2354 Will Impact The Food Industry

United States Healthcare

DM

Duane Morris LLP

Life Sciences In The Crosshairs Of Disruption

United States Healthcare

A

AlixPartners

Lie (Lay) Down!

United States Healthcare

MH

Markowitz Herbold PC

Prepare Now For Medicare Site-Neutral Payments

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Draft Regulation On The Use Of Cannabidiol (CBD) In Food Products

United States Healthcare

GA

Global Advertising Lawyers Alliance (GALA)

Déjà Vu: OPDP Again Targets Provider Branded Website Of Accelerated Approval Drug In Second Untitled Letter Of 2025

United States Healthcare

HP

Hyman, Phelps, & McNamara

FDA Approves Biocon Biologics' Bevacizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

How Health Systems Can Benefit From The Credit Tenant Lease Model For Developing Ambulatory Surgery Centers And Medical Office Buildings

United States Healthcare

AC

Ankura Consulting Group LLC

MedTech Round Table: What The Trump Administration Means For Companies And Investors

United States Healthcare

FL

Foley & Lardner

Prescription Drugs: Executive Order Aims To Lower Prices

United States Healthcare

FL

Foley & Lardner

See more

Webinars

See More

30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

The Canadian Corporate Counsel Association

Recorded on 9 Jul 2024 | 3:00 PM

Webinar: 2024 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 9 Jul 2024 | 9:00 AM

Webinar: 2024 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

What To Do When You Receive A DEA Order To Show Cause

We published a version of this post several years back (see here), but recent updates to the law and trends in DEA enforcement merit a refresher.

United States Healthcare

HP

Hyman, Phelps, & McNamara

Whistleblower Claims CVS PBM Overbilled Medicare Part D By As Much As $330M

Whistleblower Sarah Benke recently testified in a False Claims Act bench trial that Caremark, which is a pharmacy benefits manager (PBM) for Aetna Life Insurance Co., overbilled Medicare Part D...

United States Employment

HB

Hall Benefits Law

How West Virginia's HB 2354 Will Impact The Food Industry

West Virginia recently enacted significant changes under House Bill 2354, which will impact food safety standards, school nutrition programs and businesses involved...

United States Healthcare

DM

Duane Morris LLP

Life Sciences In The Crosshairs Of Disruption

United States Healthcare

A

AlixPartners

Lie (Lay) Down!

United States Healthcare

MH

Markowitz Herbold PC

Prepare Now For Medicare Site-Neutral Payments

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

The Implications Of AI-Assisted Drug Development On Patent Challenges

United States Technology

BI

Buchanan Ingersoll & Rooney PC

Draft Regulation On The Use Of Cannabidiol (CBD) In Food Products

United States Healthcare

GA

Global Advertising Lawyers Alliance (GALA)

Déjà Vu: OPDP Again Targets Provider Branded Website Of Accelerated Approval Drug In Second Untitled Letter Of 2025

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Patents

The "Lead Compound" Approach To Obviousness And Obviousness-Type Double Patenting

In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court’s determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations.

United States IP

FL

Foley & Lardner

With Ultramercial Remand, Is The Supreme Court Telegraphing View On Patent Eligibility To Federal Circuit?

After the Supreme Court decided that the personalized medicine method claims at issue in Mayo Collaborative Services v. Prometheus Laboratories, Inc. did not satisfy the patent eligibility requirements of 35 USC § 101.

United States IP

FL

Foley & Lardner

GSK And Genentech Settle Cabilly Patent Lawsuit

GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.

United States IP

BR

Beeser Ramamoorthy LLP

Supreme Court Holds That Generic Drug Manufacturers Can Challenge The Validity Of A Reference Drug’s "Use Code"

United States IP

BA

Bradley Arant Boult Cummings LLP

U.S. Supreme Court Allows Generic Drug Manufacturers To Challenge Brand’s FDA Use Codes

United States IP

VE

Vinson & Elkins LLP

Supreme Court Allows Generics To Challenge Orange Book Use Codes In Hatch-Waxman Litigation

United States Healthcare

PH

Paul Hastings LLP

Supreme Court Sides With Generic Drug Manufacturers, Closes Loophole In Hatch-Waxman Act

United States IP

PC

Perkins Coie LLP

U.S. Supreme Court Remands Myriad Case In Light Of Its Decision In Prometheus

United States IP

VE

Vinson & Elkins LLP

Federal Circuit Articulates Facts Establishing Jurisdiction In Declaratory Judgment Actions

United States IP

VE

Vinson & Elkins LLP

See more

Healthcare

Colorado Passes Bill Banning Most Physician Non-Compete Agreements

Ever since a reference to a "legislative ban on physician non-compete agreements" was made in the Colorado attorney general's Stipulated Consent Agreement and Judgment with U.S. Anesthesia Partners of Colorado, Inc., filed Feb. 26, 2024, health law practitioners in Colorado have waited to see if the Colorado General Assembly would enact such a ban...

United States Healthcare

GT

Greenberg Traurig, LLP

Health Care Marketing: The Seventh Circuit Addresses "Referrals" Under The Anti-Kickback Statute

Health care organizations working with marketers, independent sales representatives, advertising, and other consulting support to promote sales of products or services received welcomed news...

United States Healthcare

FL

Foley & Lardner

What To Do When You Receive A DEA Order To Show Cause

We published a version of this post several years back (see here), but recent updates to the law and trends in DEA enforcement merit a refresher.

United States Healthcare

HP

Hyman, Phelps, & McNamara

April 2025 Employer Regulatory And Legislative Update (Video)

United States Employment

ML

Marcum

Off-Cycle Medicare Revalidations For SNFs – Deadline Extended To August 1, 2025

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Whistleblower Claims CVS PBM Overbilled Medicare Part D By As Much As $330M

United States Employment

HB

Hall Benefits Law

In Wake Of Healthcare System Cyberattack, 22 State Attorneys General Call For Further Action On Data Privacy

United States Privacy

FH

Foley Hoag LLP

How West Virginia's HB 2354 Will Impact The Food Industry

United States Healthcare

DM

Duane Morris LLP

Standard-Essential Patent Licensing Comes To Medtech

United States IP

W

WilmerHale

See more

Life Sciences, Biotechnology & Nanotechnology

Five Trends Reshaping Pharmaceutical Manufacturing Partnerships

The pharmaceutical manufacturing landscape is undergoing a profound shift, with contract development and manufacturing organizations (CDMOs) evolving from simple capacity providers to strategic partners.

United States Commercial

GP

Goodwin Procter LLP

Off-Cycle Medicare Revalidations For SNFs – Deadline Extended To August 1, 2025

On April 17, 2025, the Centers for Medicare and Medicaid Services ("CMS") announced via a Medicare Learning Network ("MLN") update that the deadline for submission...

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Procedural Changes To Registered European Union Designs

The EU IPO commences phase I of its procedural changes to the (now called) Registered European Union Design (REUD) system on 1 May 2025...

United States IP

JA

J A Kemp LLP

Life Sciences In The Crosshairs Of Disruption

United States Healthcare

A

AlixPartners

Standard-Essential Patent Licensing Comes To Medtech

United States IP

W

WilmerHale

Virginia Amends Consumer Protection Act To Protect Reproductive And Sexual Health Information

United States Consumer

W

WilmerHale

FDA Approves Biocon Biologics' Bevacizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

MedTech Round Table: What The Trump Administration Means For Companies And Investors

United States Healthcare

FL

Foley & Lardner

Arkansas Adopts First-of-Its-Kind Bill Blocking PBMs From Owning Pharmacies, As State Attorneys General Urge Similar Congressional Action

United States Healthcare

DM

Duane Morris LLP

See more

Latest Videos

See more

Navigating FDA Compliance And Civil Litigation: Strategies For Food And Medical Product Companies (Video)

AP

Arnold & Porter

Artificial Intelligence In Healthcare (Video)

BI

Buchanan Ingersoll & Rooney PC

DSO Market Trends And 2025 Outlook ADSO Webinar Recording (Video)

B

Benesch Friedlander Coplan & Aronoff LLP

Preparing For Change: New CMS Survey Guidance Effective March 24, 2025 (Video)

SM

Sheppard Mullin Richter & Hampton

We Get Work®: An Exclusive Interview With Scipher Medicine CPO Kyla Pavlina (Podcast)

JL

Jackson Lewis P.C.

Upcoming Events

ACI 9th Advanced Summit On Food Law Regulation, Compliance And Litigation

United States Healthcare

CM

Crowell & Moring LLP

Discovery Privileges Relating To Quality Assurance Activities In Healthcare

United States Healthcare

WE

Wilson Elser Moskowitz Edelman & Dicker LLP

Connect With Gowling WLG At BIO 2025

United States Healthcare

GW

Gowling WLG

29th Annual Compliance Institute

United States Healthcare

BB

Bass, Berry & Sims

Speaking Engagement

16th Annual Advance Forum On Managed Care Disputes And Litigation: Unpacking Loper Bright For The MCO Industry And Adjusting To A Post-Chevron World

United States Healthcare

FH

Foley Hoag LLP

Cell And Gene Therapies Roundtable

United States Healthcare

M

Mintz

Asembia’s AXS25 Summit

United States Healthcare

BB

Bass, Berry & Sims

Understanding DOJ's Evaluation Of Corporate Compliance Programs

United States Healthcare

HK

Holland & Knight

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More